OMDA Stock — Omada Health, Inc.

Omada Health, Inc. (OMDA)

Updated October 16, 2026.

OMDA is a Stock. Total return is -7.2% over the past 1.4 years, 38.0 points behind SPY at 30.8%.

Omada Health is a virtual care company that delivers digital health programs targeting cardiometabolic conditions like prediabetes and diabetes, musculoskeletal disorders, behavioral health needs, and weight management to employers, health plans, and pharmacy benefits managers. The company does not currently have an established distribution schedule. This business appeals primarily to those seeking exposure to digital health and preventive care rather than income-focused investors.

OMDA performance versus SPY

Price and return data through 2026-10-16.

Total return is -7.2% over the past 1.4 years, 38.0 points behind SPY at 30.8%. Its deepest 1-year drawdown was 59.1%.

OMDA key facts

Asset type

Stock

Asset class

Equity

Inception date

06/05/2025

Distribution frequency

None

Last close

$17.63 (as of 2026-10-16)

Market cap

$1,079,250,474

Average volume

804186.0

Payout ratio

0.0%

P/E ratio

73.46

Forward P/E

136.9863

EPS

$0.24

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

OMDA risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 59.1%.

Who may consider OMDA — and who may not

It is a weaker fit for investors who need monthly cash flow (OMDA does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on OMDA

• All tickers starting with O

Tagged: Healthcare.

Frequently asked questions